Cargando…
Immunotherapy in inflammatory bowel disease: Novel and emerging treatments
Inflammatory bowel disease (IBD) is a chronic disabling inflammatory process that affects young individuals, with growing incidence. The etiopathogenesis of IBD remains poorly understood. A combination of genetic and environmental factors triggers an inadequate immune response against the commensal...
Autores principales: | Catalan-Serra, Ignacio, Brenna, Øystein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314405/ https://www.ncbi.nlm.nih.gov/pubmed/29624476 http://dx.doi.org/10.1080/21645515.2018.1461297 |
Ejemplares similares
-
Revisiting the “starved gut” hypothesis in inflammatory bowel disease
por: Colgan, Sean P., et al.
Publicado: (2023) -
Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
por: Li, Mengfan, et al.
Publicado: (2022) -
Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review
por: Zarenezhad, Elham, et al.
Publicado: (2023) -
Anemia in Inflammatory Bowel Disease: An Under-Estimated Problem?
por: Rogler, Gerhard, et al.
Publicado: (2015) -
Fecal Fungal Microbiota (Mycobiome) Study as a Potential Tool for Precision Medicine in Inflammatory Bowel Disease
por: Balderramo, Domingo C., et al.
Publicado: (2023)